|Last Price$56.97||Day Change (%)0.69%|
|Open Price$56.74||Day Change ($)0.39|
|Day Range56.25–57.19||52-Week Range41.97–59.60|
As of Wed 12/24/2014 01:00 PM EST | USD
Mylan Launches First Generic Version of Vivelle-DOT®
World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017
Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS
Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017
UPDATE: Cypress, Spansion shares rally on merger plan
Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.
These mutual funds have far more than their recent success going for them.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.